Market Tracker

08/26 5:16pm ET

Exelixis Inc (NASDAQ:EXEL)

10.96
Delayed Data
As of Aug 26
 +0.05 / +0.46%
Today’s Change
3.55
Today|||52-Week Range
11.74
+94.33%
Year-to-Date
Why Exelixis (EXEL) Could Be Positioned for a Surge
Aug 26 / Zacks.com - Paid Partner Content
4 Biotech Stock Charts You Must See
Aug 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close10.91
Today’s open10.94
Day’s range10.71 - 11.07
Volume4,638,672
Average volume (3 months)6,091,183
Market cap$2.5B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+14.81%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...-0.31-0.70%
PRAHPRA Health Sciences ...+0.87+1.72%
DBVTDBV Technologies SA+0.06+0.17%
PRXLPAREXEL Internationa...+0.75+1.10%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts